APA (7th ed.) Citation

Chen, T., Lin, C., Lo, W., Hsieh, C., Lien, M., Lin, C., . . . Yeh, S. (2022). Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies. International journal of hematology, 115(4), 525-533. https://doi.org/10.1007/s12185-021-03280-x

Chicago Style (17th ed.) Citation

Chen, Tzu-Ting, et al. "Antithymocyte Globulin Plus Post-transplant Cyclophosphamide Combination as Graft-versus-host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies." International Journal of Hematology 115, no. 4 (2022): 525-533. https://doi.org/10.1007/s12185-021-03280-x.

MLA (9th ed.) Citation

Chen, Tzu-Ting, et al. "Antithymocyte Globulin Plus Post-transplant Cyclophosphamide Combination as Graft-versus-host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies." International Journal of Hematology, vol. 115, no. 4, 2022, pp. 525-533, https://doi.org/10.1007/s12185-021-03280-x.